Credit Rating Assignment
Niva Bupa Assigned Highest ICRA ‘AAA (Stable)’ Issuer Rating
NSE
nivabupa
BSE
544286
Niva Bupa Health Insurance Company Limited informed the stock exchanges that ICRA Limited has assigned an Issuer Rating of [ICRA]AAA (Stable) to the company. The highest investment-grade issuer rating reflects ICRA’s opinion regarding the company’s strong overall credit profile and ability to meet its financial obligations.
PRICE-SENSITIVE TRIGGER
Event: ICRA Assigns Issuer Rating
Type: Credit Rating Assignment
Impact: Positive
Immediate Effect: The assignment of the [ICRA]AAA (Stable) issuer rating strengthens Niva Bupa’s credit profile and reinforces its financial credibility among lenders, investors, and other stakeholders.
Financials:
Key Metrics:
- Issuer Rating: [ICRA]AAA (Stable)
- Rating Agency: ICRA Limited
- Instrument Rated: Issuer Rating
- Rated Amount: Not Applicable
- Rating Date: 15 July 2026
- Financial Sector Regulator (FSR): Not Applicable
Highlight:
- ICRA has assigned Niva Bupa Health Insurance its highest long-term issuer credit rating of [ICRA]AAA with a Stable outlook.
What Happened ?
Niva Bupa Health Insurance informed the exchanges that it has received a communication from ICRA Limited assigning an Issuer Rating of [ICRA]AAA (Stable).
The company received the rating letter on 15 July 2026 at 2:24 PM (IST) and disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
According to ICRA, the assigned rating will be subject to periodic surveillance and may be reviewed based on changes in the company’s financial profile or other relevant developments.
key details
Credit Rating Assignment:
ICRA assigned the following issuer rating:
- Issuer Rating: [ICRA]AAA (Stable)
- Rating Agency: ICRA Limited
- Rating Status: Newly Assigned
- Rating Date: 15 July 2026
The rating represents ICRA’s opinion on the company’s overall creditworthiness rather than a specific debt instrument.
Meaning of the Rating:
- The assigned [ICRA]AAA (Stable) rating is the highest long-term credit rating within ICRA’s domestic rating scale.
- The Stable outlook indicates ICRA’s expectation that the company’s credit profile is likely to remain consistent over the near to medium term, assuming no material adverse changes in business or financial conditions.
Regulatory Disclosure:
- The disclosure has been made under Regulation 30 of the SEBI (LODR) Regulations, 2015.
- The rating communication was received by the company on 15 July 2026.
- The rating letter has been made available to investors through the stock exchange filing.
Business Impact:
The assignment of a top-tier issuer rating may provide several strategic benefits:
- Strengthens overall market credibility.
- Enhances confidence among lenders and institutional investors.
- Supports access to future funding at competitive terms.
- Reinforces the company’s financial standing within the health insurance sector.
Risk Analysis
Summary:
- The disclosure relates only to an issuer credit rating assignment and does not include any operational or financial performance update. Future rating actions will remain subject to periodic surveillance by ICRA.
Key Risks:
- Future rating reviews will depend on business performance and capital adequacy.
- Any significant deterioration in profitability, solvency, or financial profile could affect future rating actions.
- The Stable outlook may be revised if material business or regulatory developments occur.
Worst Case:
- A material weakening in the company’s financial profile or operating environment could lead to a revision of the outlook or credit rating during future surveillance reviews.
Risk Level: Low
Company Commentary
- ICRA Limited has assigned [ICRA]AAA (Stable) as the company’s issuer rating.
- The company received the rating letter on 15 July 2026.
- The disclosure has been made pursuant to SEBI Listing Regulations.
- The company has also made the information available on its corporate website.
Official Exchange Filing: Niva Bupa Health Insurance Company Limited
